A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Grooming brand Harry’s picks Team: Changing Minds as winner of its Open Minds Initiative for mental health; brand to provide support, US$5M donation over three years to the program that will leverage video games, sports to train mental health responders
Published: April 29, 2022 by PR Newswire
Petros Pharmaceuticals reports positive results from draft label comprehension study of OTC erectile dysfunction drug Stendra avanafil; 30 million men have erectile dysfunction in US, with 25% receiving oral therapy
Published: April 27, 2022 by GlobeNewswire
Merck stops Phase 3 trial of injectable Keytruda, Lynparza combination to treat metastatic castration-resistant prostate cancer; analysis shows drug combo did not show benefit to survival compared with abiraterone acetate or enzalutamide
Published: April 04, 2022 by BZ Briefs Pharma
Osteoporosis often overlooked in men, as only 6% of men tested for disease compared to 12% of women; oral bisphosphonates most prescribed treatment, yet only 54%-to-71% of men continue taking medication after one year: study
Published: March 30, 2022 by McKnight's Long-Term Care News
FDA approves Novartis’ Pluvicto intravenous lutetium Lu 177 vipivotide tetraxetan to treat progressive, PSMA-positive metastatic castration-resistant prostate cancer; prostate cancer second leading cause of cancer-related deaths in US men
Published: March 25, 2022 by Novartis AG

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count